The Mexican consensus on nonalcoholic fatty liver disease

被引：40

作者：

Bernal-Reyes, R. ^{[1
]}

Castro-Narro, G. ^{[2
]}

Male-Velazquez, R. ^{[3
]}

Carmona-Sanchez, R. ^{[4
]}

Gonzalez-Huezo, M. S. ^{[5
]}

Garcia-Juarez, I. ^{[2
]}

Chavez-Tapia, N. ^{[6
]}

Aguilar-Salinas, C. ^{[7
]}

Aiza-Haddad, I. ^{[8
]}

Ballesteros-Amozurrutia, M. A. ^{[9
]}

Bosques-Padilla, F. ^{[10
]}

Castillo-Barradas, M. ^{[11
]}

Chavez-Barrera, J. A. ^{[12
]}

Cisneros-Garza, L. ^{[13
]}

Flores-Calderon, J. ^{[14
]}

Garcia-Compean, D. ^{[13
]}

Gutierrez-Grobe, Y. ^{[6
]}

Higuera de la Tijera, M. F. ^{[15
]}

Kershenobich-Stalnikowitz, D. ^{[7
]}

Ladron de Guevara-Cetina, L. ^{[16
]}

Lizardi-Cervera, J. ^{[6
]}

Lopez-Cossio, J. A. ^{[5
]}

Martinez-Vazquez, S. ^{[2
]}

Marquez-Guillen, E. ^{[7
]}

Mendez-Sanchez, N. ^{[6
]}

Moreno-Alcantar, R. ^{[17
]}

Poo-Ramirez, J. L. ^{[18
]}

Ramos-Martinez, P. ^{[19
]}

Rodriguez-Hernandez, H. ^{[20
]}

Sanchez-Avila, J. F. ^{[21
]}

Stoopen-Rometti, M. ^{[22
]}

Torre-Delgadillo, A. ^{[2
]}

Torres-Villalobos, G. ^{[7
]}

Trejo-Estrada, R. ^{[23
]}

Uribe-Esquivel, M. ^{[6
]}

Velarde-Ruiz Valazco, J. A. ^{[24
]}

机构：

[1] Soc Espanola Beneficencia, Pachuca, Hidalgo, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico

[3] Inst Salud Digest & Hepat SA CV, Guadalajara, Jalisco, Mexico

[4] Consulta Privada, San Luis Potosi, Mexico

[5] ISSSEMYM, Serv Gastroenterol & Endoscopia GI, Metepec, Estado De Mexic, Mexico

[6] Fdn Clin Med Sur, Serv Gastroenterol, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[8] Hosp Angeles Lomas, Clin Enfermedades Hepat, Mexico City, DF, Mexico

[9] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[10] Ctr Med Zambrano Hell, Monterrey, Nuevo Leon, Mexico

[11] Hosp Especialidades Ctr Med La Raza, Ctr Med La Raza IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[12] IMSS, Ctr Med La Raza, Serv Gastroenterol Pediat, Hosp Gen, Mexico City, DF, Mexico

[13] Hosp Univ UANL, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico

[14] IMSS, Ctr Med Siglo 21, Hosp Pediat, Serv Gastroenterol, Mexico City, DF, Mexico

[15] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[16] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[17] Hosp Especialidades Ctr Med La Raza, Ctr Med Siglo 21, IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[18] Tec Monterrey, Ctr Innovac & Educ Ejecut, Mexico City, DF, Mexico

[19] Ctr Patol Especializada SLP, San Luis Potosi, Mexico

[20] Hosp Especialidades Ctr Med La Raza, United Invest Biomed AMCCI, Durango, Mexico

[21] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico

[22] Ctr Diagnost CT Scanner Lomas Altas, Mexico City, DF, Mexico

[23] Ctr Med ABC, Mexico City, DF, Mexico

[24] Hosp Civil Guadalajara, Dept Gastroenterol, Guadalajara, Jalisco, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2019年 / 84卷 / 01期

关键词：

Nonalcoholic fatty liver disease; Mexican consensus; CONTROLLED TRANSIENT ELASTOGRAPHY; INTRAHEPATIC LIPID-CONTENT; PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA HCC; DE-NOVO LIPOGENESIS; LONG-TERM OUTCOMES; VITAMIN-E; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE;

D O I：

10.1016/j.rgmx.2018.11.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociacion Mexicana de Gastroenterologia and the Asociacion Mexicana de Hepatologia to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathaphysialogy, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty Liver disease. (C) 2019 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：69 / 99

页数：31

共 50 条

[21] Nonalcoholic fatty liver disease
Adams, LA
Angulo, P
Lindor, KD
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) : 899 - 905
[22] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
Yalamanchili, Kanthi
Saadeh, Sherif
Klintmalm, Goeran B.
Jennings, Linda W.
Davis, Gary L.
LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
[23] Nonalcoholic Fatty Liver Disease
Fusillo, Steven
Rudolph, Bryan
PEDIATRICS IN REVIEW, 2015, 36 (05) : 198 - 206
[24] Nonalcoholic fatty liver disease
Erickson, Sandra K.
JOURNAL OF LIPID RESEARCH, 2009, 50 : S412 - S416
[25] Nonalcoholic fatty liver disease
Krawczyk, Marcin
Bonfrate, Leonilde
Portincasa, Piero
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (05) : 695 - 708
[26] Nonalcoholic fatty liver disease
Adams, Leon A.
Lindor, Keith D.
ANNALS OF EPIDEMIOLOGY, 2007, 17 (11) : 863 - 869
[27] Nonalcoholic Fatty Liver Disease
Law, Kathryn
Brunt, Elizabeth M.
CLINICS IN LIVER DISEASE, 2010, 14 (04) : 591 - +
[28] Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
不详
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05)
[29] Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need
Zhou, Yu-Jie
Wong, Vincent Wai-Sun
Zheng, Ming-Hua
HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (03) : 388 - 390
[30] The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
Sharma, Mithun
Mitnala, Shasikala
Vishnubhotla, Ravi K.
Mukherjee, Rathin
Reddy, Duvvur N.
Rao, Padaki N.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 147 - 158

← 1 2 3 4 5 →